Nov 13 (Reuters) - U.S. pharmaceutical firm Akorn Inc. and Indian drug maker FDC Ltd said they have signed an exclusive development and supply agreement for two ophthalmic suspension drug products.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results